Scientific publication with Newspaper speed
HIGH IMPACT, OUTSTANDING EDITORIAL BOARD, OVERNIGHT PUBLICATION, OPEN ACCESS, PROMOTION, HIGH VISIBILITY
Cancer research has entered a new era where the new discoveries provide a deeper insight into the mechanisms of cancer development.
The journals of this new era cover not only basic cancer research, but also the clinical and social problems posed by cancer, the link between cancer development and aging, and cancer prevention.
Oncotarget publishes high-impact manuscripts that offer biological and translational insight into these problems. The main scope of the Journal is to focus on molecular and cellular biology of cancer, pathology, gerontology, prevention and epidemiology, and bioinformatics.
Oncotarget is preparing to launch independent sections to extend the scope of the journal. The topics will be Cellular & Molecular Biology, Pathology, Bioinformatics, and Pharmacology. Publish your Research Paper on any of these topics in a journal with impact factor 6.63
Please submit the papers to the new section: Gerontology & Aging (Gerotarget)
If your paper was mistakenly rejected by other leading journals, you may submit it to Oncotarget (see our unique 2 night policy) together with peer-reviews obtained from the other journal and rebuttal letter.
Under supervision of Oncotarget's editors and editorial board, Oncotarget now launches Oncoscience, a sister peer-reviewed journal, on all topics in cancer research. The main criteria for publication in Oncoscience is high-quality design and execution of the study, high-quality results and clear conclusions supported by the data.
|07/30/2014||New IF: IF2013 = 6.63|
|07/23/2014||Elsevier has released the latest Journal Metrics based on Scopus data: SCImago Journal Rank (SJR). For Oncotarget, SJR 2013 increased by 24% compared with the last year SJR 2012.|
|12/30/2013||Our new submission system is online oncotarget.msubmit.net. See link for earlier papers.|
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
Copyright @ 2008-2014 Impact Journals, LLC. All rights reserved.